By Stacy Brown NNPA Senior National Correspondent Bill Cosby said his widely criticized admonition that young Black men should “pull their pants up” was less about fashion...

The systemic bias that has historically failed Black people in the USA is no less evident in Canada. That reality is laid bare in the...

Claude Cummings has been unanimously nominated by the NNPA Executive Committee to receive the NNPA 2025 National Leadership Award for outstanding leadership and achievement...

People in the News

Wednesday, September 17, 2025

People in the News

Wednesday, September 17, 2025

Nova Max Glucose Test Strips recalled because of false, abnormally high blood glucose results

indexNova Diabetes Care initiated a voluntary recall of 21 lots of the Nova Max Glucose Test Strips distributed both in the USA and outside the continental USA. Nova Max Plus glucose meter kits include test strips from the recalled lots are also included in this voluntary recall.

The company has recently determined some of the blood glucose test strips contained within the indicated Nova Max Glucose Test Strip lots and Nova Max Plus glucose meter kits may report a false, abnormally high blood glucose result. A false abnormally high blood glucose result could, under certain conditions, result in an insulin dosing error that could lead to a serious health risk requiring immediate medical attention.

Upon identifying the issue, Nova Diabetes Care notified all registered users, health care professionals, pharmacies, and distributors where the Nova Max Glucose Test Strip and Nova Max Plus glucose meter kit are recommended or sold.

Those who use, recommend clinically, or sell Nova Max Glucose Test Strips for blood glucose testing should immediately discontinue using or distributing glucose test strips from the recalled lots.

Customers can check to confirm if they have blood glucose test strips from the affected lots on the attached list, by visiting www.novacares.com/news/nova-max-recall.php or by contacting Nova Diabetes Care customer service at 1-800-681-7390.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:

Complete and submit the report Online: www.fda.gov/MedWatch/report.htm

Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.